Skip to main content
VENTURE LIFE GROUP PLC logo

VENTURE LIFE GROUP PLC — Investor Relations & Filings

Ticker · VLG ISIN · GB00BFPM8908 LEI · 213800S8CZUPLAB2KC70 IL Manufacturing
Open in API
Filings indexed 436 across all filing types
Latest filing 2021-12-20 Board/Management Inform…
Country GB United Kingdom
Listing IL VLG

About VENTURE LIFE GROUP PLC

https://www.venture-life.com/

Venture Life Group PLC is a consumer self-care company that develops, manufactures, and distributes products for the global market. The company focuses on non-prescription items that consumers can purchase directly, addressing preventative wellness and quality of life issues, particularly those related to an aging population. Its product portfolio encompasses a range of categories, including medical devices, food supplements, dermo-cosmetics, and oral healthcare. Venture Life manages the entire product lifecycle, from initial concept and in-house manufacturing to international commercialization through a network of global partners.

Recent filings

Filing Released Lang Actions
Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement filed via RNS (RNS Number : 2514W). The title explicitly states 'Directorate Change' and the content confirms that Mr. Daniel Wells has joined the Board as Chief Financial Officer with immediate effect. This directly corresponds to the definition of Board/Management Information.
2021-12-20 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document is very short (1940 characters) and begins with 'RNS Number : 6047V'. It discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific market operational announcement. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement that does not fit into the specific financial reporting categories (like 10-K, ER, IR). Therefore, the most appropriate classification is the general Regulatory Filings category (RNS).
2021-12-14 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number : 6042V' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory announcement related to trading mechanics, not a comprehensive financial report (like 10-K or IR) or a management change (MANG). Given its nature as a general regulatory notice disseminated via the RNS system, and since it doesn't fit the specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory announcement fallback category, RNS.
2021-12-14 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document explicitly states 'RNS Number : 5768U' and contains detailed disclosures regarding share transactions by company Directors (Jerry Randall, Sharon Collins, Gianluca Braguti, Carl Dempsey). The disclosure format follows regulatory requirements, specifically mentioning compliance with 'article 19(3) of the Market Abuse Regulation'. This type of filing, reporting personal share transactions by directors, directly corresponds to the definition of Director's Dealing. The presence of 'RNS' branding and the structure suggest it is a regulatory announcement, but the specific content points overwhelmingly to Director's Dealing (DIRS).
2021-12-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1940 characters) and contains an RNS Number (1907U) and mentions RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA). The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific type of market announcement. This type of ad-hoc regulatory announcement that doesn't fit into the specific financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory filing/announcement category, RNS. It is not a report itself, but a notification of a trading event.
2021-12-01 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement regarding trading procedures, not a comprehensive financial report or a standard earnings release. Given its nature as a general regulatory notice disseminated via the RNS system that doesn't fit other specific categories (like DIRS, DIV, or ER), the most appropriate classification is the general Regulatory Filings category (RNS). The document length (1923 chars) is short, but it contains the primary information itself, rather than announcing a separate, attached report, thus making RNS more suitable than RPA.
2021-12-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.